Understanding Skeletal Dysplasias—Recent Advances in Genetics
Nov 24, 2020
Webinar information
Date: December 17, 2020
Time: 9:00 AM PST / 18:00 CET
Duration: 1 hour
Speaker: Alicia Scocchia

Date: December 17, 2020
Time:  9:00 AM PST / 18:00 CET

Skeletal dysplasias encompass hundreds of heritable conditions involving abnormalities of cartilage and bone. Suspicion of skeletal dysplasias often results from appreciating a difference in growth patterns or disproportionate short stature, which may be identified prenatally. Identifying a molecular diagnosis for an individual with a skeletal dysplasia can lead to improved clinical care, guide future medical management, and inform familial recurrence. As we leverage high-throughput sequencing technologies for gene discovery, our understanding of the molecular basis of these conditions is expected to continue growing.

During this educational webinar, Clinical Liaison  Alicia Scocchia, MS, CGC, will review molecular causes of skeletal dysplasias and discuss genetic testing considerations. We will also share our experience at Blueprint Genetics with diagnostic panel testing for individuals with these conditions. Case examples will be explored highlighting complex clinical presentations and the involvement of copy number variants in diagnostic findings.

Webinar objectives:

  • Recognize common molecular causes of skeletal dysplasias
  • Describe genetic testing options and testing considerations for clinicians
  • Examine the diagnostic yield, most common genes contributing to diagnostic findings, and distribution of variant types reported in a group of individuals receiving panel testing for these conditions
  • Identify challenges in comprehensive molecular diagnostics for individuals with suspected skeletal dysplasias



Alicia Scocchia

Alicia Scocchia, MS, CGC, LGC, attended graduate school at Sarah Lawrence College (MS in Human Genetics). She previously counseled patients clinically with a focus in oncology and population genomics as well as performed interpretation, reporting, and client support for a clinical whole genome sequencing test intended for patients with rare disease. Currently, she is Clinical Liaison at Blueprint Genetics based in San Diego, CA.

More details here

Last modified: December 18, 2020